No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
Sign up to see all 4.
Sign up to see all 3.
No insider has filed a notice of proposed sale (Form 144) for Blue Owl Capital Corp III in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
EN
Exor N.V.
|
185.9M | 150.73% | +3.4M (+1.9%) | 2023 | 19.3% | |
|
Shares held by quarter
Peak holding185.9M (Q2'26)
Change over 8 quarters+21.4M
Share of the company150.730%
|
||||||
|
OA
Orbimed Advisors LLC
|
5.7M | 4.60% | −530.7K (−8.5%) | ≤2021 | 0.6% | |
|
Shares held by quarter
Peak holding12.0M (Q3'24)
Change over 8 quarters−6.4M
Share of the company4.600%
|
||||||
5 more super investors behind a free account
See every manager holding Blue Owl Capital Corp III, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FT
First Trust Specialty Finance & Financial Opportunities Fund
First Trust Specialty Finance & Financial Opportunities Fund
|
$3.72M | 250.0K | 0.20% | 5.91% | November 29, 2024 |
|
BP
RBB Fund, Inc.
|
$2.51M | 168.8K | 0.14% | 0.41% | November 30, 2024 |
3 more funds behind a free account
See every fund holding Blue Owl Capital Corp III and how much of the fund the position is.
Sign up freeLoading...